Shire "outperform," target price reduced - newratings.com
newratings.com, Germany - 22 hours ago
Shire expects Vyvanse to be able to capture 6.3% market share by March 2008. With the US approval of the adult indication of Vyvanse expected by April 2008, …
Find Out More:
Books:
- Reading, Writing, and Rage : The Terrible Price Paid by Victims of School Failure
- Pivotal Response Treatments for Autism: Communication, Social, & Academic Development
- Activity Schedules for Children With Autism: Teaching Independent Behavior (Topics in Autism) (Topics in Autism)
- Out of the Fog: Treatment Options and Coping Strategies for Adult Attention Deficit Disorders
- ADHD Adult
February 23rd, 2008
Vyvanse
Leave a Reply